Another emerging arbovirus, another emerging vaccine: Targeting Zika virus

Vaccine

Volumn 34, Issue 20, 2016, Pages 2291-2293

  Palacios, Ricardo ^a   Poland, Gregory A ^b   Kalil, Jorge ^a,c  

^a INSTITUTO BUTANTAN   (Brazil)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; MONOCLONAL ANTIBODY; RUBELLA VACCINE; VIRUS VACCINE;

CONGENITAL RUBELLA SYNDROME; EDITORIAL; GUILLAIN BARRE SYNDROME; HUMAN; MICROCEPHALY; POSITIVE-STRAND RNA VIRUS; PRIORITY JOURNAL; RNA VIRUS INFECTION; VIRUS VIRULENCE; ZIKA VIRUS; ZIKA VIRUS INFECTION; COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH;

COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH; HUMANS; MICROCEPHALY; VIRAL VACCINES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84962768172     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.03.059     Document Type: Editorial

References (23)

1. Dick G.W., Kitchen S.F., Haddow A.J. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952, 46(5):509-520.
2. Dick G.W. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg 1952, 46(5):521-534.
3. Heang V., Yasuda C.Y., Sovann L., Haddow A.D., Travassos da Rosa A.P., Tesh R.B., et al. Zika virus infection, Cambodia, 2010. Emerg Infect Dis 2012, 18(2):349-351.
4. Duffy M.R., Chen T.H., Hancock W.T., Powers A.M., Kool J.L., Lanciotti R.S., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009, 360(24):2536-2543.
5. European Centre for Disease Prevention and Control Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome (first update) 2016.
6. Geser A., Henderson B.E., Christensen S. A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ 1970, 43(4):539-552.
7. Mallet H.-P.V., Musso A.-L. D. Bilan de l'épidémie a virus ZIKA en Polynésie Française. BISES: Bulletin d'information sanitaires épidémiologiques et statistiques 2015, 1-5.
8. Faye O., Freire C.C., Iamarino A., Faye O., de Oliveira J.V., Diallo M., et al. Molecular evolution of Zika virus during its emergence in the 20(th) century. PLoS Negl Trop Dis 2014, 8(1):e2636.
9. Cao-Lormeau V.-M., Blake A., Mons S., Lastère S., Roche C., Vanhomwegen J., et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016, pii: S0140-6736(16)00562-6. [ePub ahead of print].
10. Campos G.S., Bandeira A.C., Sardi S.I. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis 2015, 21(10):1885-1886.
11. Zanluca C., Melo V.C., Mosimann A.L., Santos G.I., Santos C.N., Luz K., et al. First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz 2015, 110(4):569-572.
12. Brazil, M.d.S. Evento de saúde pública relacionado aos casos de Febre do Zika 2015, 14-Aug-2015; Available from: http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/secretarias/svs/noticias-svs/19139-evento-de-saude-publica-relacionado-aos-casos-de-febre-do-zika [accessed 06.02.16].
13. Brazil - Secretaria de Vigilância em Saúde Situação epidemiológica de ocorrência de microcefalias no Brasil, 2015. Boletim Epidemiológico 2015, 46:1-3.
14. Oliveira Melo A.S., Malinger G., Ximenes R., Szejnfeld P.O., Alves Sampaio S., Bispo de Filippis A.M. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?. Ultrasound Obstet Gynecol 2016, 47(1):6-7.
15. Brazil, C.d.O.d.E.e.S.P.s.M. Monitoramento dos casos de microcefalia no Brasil. Informe Epidemiológico 2016.
16. Bogoch I.I., Brady O.J., Kraemer M.U., German M., Creatore M.I., Kulkarni M.A., et al. Anticipating the international spread of Zika virus from Brazil. Lancet 2016, 387(10016):335-336.
17. Direction de la santé - Bureau de veille sanitaire et Centre Hospitalier de Polynésie française Note sur les investigations autour des malformations cérébrales congénitales ayant suivi l'épidémie de Zika de 2013-2014. Bull Surveill Sanit 2015, Complement 1.
18. Revello M.G., Lazzarotto T., Guerra B., Spinillo A., Ferrazzi E., Kustermann A., et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 2014, 370(14):1316-1326.
19. Dixit R., Herz J., Dalton R., Booy R. Benefits of using heterologous polyclonal antibodies and potential application to new and undertreated infectious pathogens. Vaccine 2016.
20. Plotkin S.A. The history of rubella and rubella vaccination leading to elimination. Clin Infect Dis 2006, 43(Suppl. 3):S164-S168.
21. Sencer D.J., Millar J.D. Reflections on the 1976 swine flu vaccination program. Emerg Infect Dis 2006, 12(1):29-33.
22. Kwong J.C., Vasa P.P., Campitelli M.A., Hawken S., Wilson K., Rosella L.C., et al. Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013, 13(9):769-776.
23. Boseley S. WHO: several hundred thousand Ebola vaccine doses expected by mid-2015 2014, The Guardian, London.